labyrx / LABYRX |

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.labyrx.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	LABYRX \|
Description	TARGETED CANCER top of page ABOUT US ABOUT LABYRX LEADERSHIP TECHNOLOGY OUR APPROACH LABYRINTHIN THERAPEUTIC APPROACH THE LABVAX PLATFORM SYNTHETIC PEPTIDES PROGRAMS OUR
Keywords	N/A

Server Information

WebSite	labyrx.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

labyrx.com Valuation

US$1,911

Last updated: 2023-05-11 02:17:04

labyrx.com has Semrush global rank of 0. labyrx.com has an estimated worth of US$ 1,911, based on its estimated Ads revenue. labyrx.com receives approximately 220 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, labyrx.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,911
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$52
Yearly Ads Revenue	US$635
Daily Unique Visitors	14
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
labyrx.com.	A	600	IP: 23.236.62.147
labyrx.com.	NS	3600	NS Record: pdns01.domaincontrol.com.
labyrx.com.	NS	3600	NS Record: pdns02.domaincontrol.com.
labyrx.com.	MX	3600	MX Record: 0 labyrx-com.mail.protection.outlook.com.
labyrx.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-11 02:17:04

top of page ABOUT US ABOUT LABYRX LEADERSHIP TECHNOLOGY OUR APPROACH LABYRINTHIN THERAPEUTIC APPROACH THE LABVAX PLATFORM SYNTHETIC PEPTIDES PROGRAMS OUR PLATFORMS PIPELINE NEWS PRESENTATIONS ANNOUNCEMENTS PUBLICATIONS CONTACT US TARGETED CANCER THERAPEUTICS LEARN MORE LabyRx has developed unconventional cancer therapeutics directed against a novel cancer target. Our unique target is called Labyrinthin*. Our lead product, LabVax, is a Labyrinthin-derived synthetic peptide vaccine that recruits the body’s immune cells to attack adenocarcinomas cancers, which represent approximately 40% of all cancers and over 60% of all cancer deaths. OUR VISION To bring novel therapies harnessing our body’s own immune system to treat patients suffering from a wide range of adenocarcinoma cancers. bottom of

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 03 Nov 2021 21:35:26 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.labyrx.com/
strict-transport-security: max-age=120
Age: 66662
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=96
X-Seen-By: gv/XVF9HsGpk8A2KWukUzCWfEJXUOf1J0Ah0dFlolkk=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgTe3xZ//Nn3ncOxm4L8+OZ,m0j2EEknGIVUW/liY8BLLtwwHRZu3rPLuvgpbcEVPv9lstwothkaV5CJ10PE1l/n,2d58ifebGbosy5xc+FRalkxBibSZFcjAuViDxCLIwpSyOm736R9JppF//LSODpcIbSaoQsF1v/5zIpNIMVlhWg==,2UNV7KOq4oGjA5+PKsX47Acb9tPMRl4SW2bhgA9BBDtYgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1635975326.52316151585173427019
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Wed, 03 Nov 2021 21:35:26 GMT
content-type: text/html; charset=UTF-8
content-length: 345412
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"8d12b48712d5e76fd35738920dd597cc"
content-language: en-US
strict-transport-security: max-age=120
age: 91791
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=42; Max-Age=20; Expires=Tue, 02 Nov 2021 20:05:55 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
x-seen-by: wmgbEcS9zOENaefw7bU4YUbeT7LzRsCznpqBWyjuyLU=,gv/XVF9HsGpk8A2KWukUzOwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVho24eAEbfscWhcpKw1HIzZ,m0j2EEknGIVUW/liY8BLLjPDFZzqr/nlb7YyA5Dm8UnF+NHRbelhY0dsZwjDYnLI,2d58ifebGbosy5xc+FRaluJYv16WcCtyjrCy9nzTrZNtuqk3Xj4gO0K0NORfd0r50UosE1Ld2vfMJlNWqJqFGA==,2UNV7KOq4oGjA5+PKsX47KH2oyd+0TIFyhZ1fYl9fAAfbJaKSXYQ/lskq2jK6SGP
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1635975326.6998083661262231
x-content-type-options: nosniff
set-cookie: TS01e85bed=01f0e93131c3ba395e5088a92fa817cda933e2cefca848b0e4f552280e5e19fb324a2f256484dbe8d9feca03fd66a03cd16d146987; Path=/;SameSite=none;Secure
server: Pepyaka/1.15.10

labyrx.com Whois Information

Domain Name: LABYRX.COM
Registry Domain ID: 2280873549_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-07-02T03:01:06Z
Creation Date: 2018-06-30T06:01:59Z
Registry Expiry Date: 2023-06-30T06:01:59Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: PDNS01.DOMAINCONTROL.COM
Name Server: PDNS02.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-10-14T07:22:05Z <<<

labyrx.com valuation and analysis